EVLV

Business Context and Reporting Period

Company: Evolv Technologies Holdings, Inc. (EVLV)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2025
Business Overview: Evolv is a security technology company providing AI-powered screening solutions (Evolv Express for people, Evolv eXpedite for bags) via a Security-as-a-Service model. The company serves education, healthcare, sports, and industrial sectors. In 2025, the company added nearly 250 new customers and launched Evolv eXpedite. The company is classified as a non-accelerated filer and smaller reporting company.

Key Financial Metrics

Note: 2024 RPO is derived from the 13% increase stated in the text relative to the 2025 figure of $293.6 million.

Material Changes vs. Prior Period

• Revenue Growth: Total revenue increased 40% year-over-year, driven by a 235% increase in product revenue (due to the "purchase subscription" model) and a 29% increase in subscription revenue.
• Profitability Improvement: Net loss narrowed by 39% to $33.1 million. Adjusted EBITDA improved by $32.1 million, turning positive for the first time.
• Debt Financing: In July 2025, the company entered a $75.0 million credit facility. As of year-end, $30.0 million was drawn, compared to no debt in 2024.
• Operational Restructuring: The company implemented a reduction in force in January 2025 affecting 41 employees, resulting in $2.7 million in restructuring costs.
• Supply Chain: Entered a new contract manufacturing agreement with Plexus Corp. in November 2025 to diversify from its primary manufacturer, Columbia Tech.
• Legal Settlement: Reached a settlement in principle for a class action lawsuit for $15.0 million, with an estimated $14.0 million insurance recovery.

Guidance, Outlook, Risks, and Contingencies

Outlook and Strategy: Management expects to continue generating losses in the foreseeable future while investing in growth. The company is shifting focus toward pure subscription and purchase subscription models, phasing out the distributor licensing model which expired in December 2025. International expansion is planned but remains selective.

Key Risks:

• Internal Controls: The company disclosed material weaknesses in internal control over financial reporting, which led to restatements of prior periods (2022-2024). While some weaknesses were remediated by year-end 2025, others remain, including deficiencies in the control environment and IT general controls.
• Litigation and Regulatory: Ongoing SEC investigation regarding marketing practices and revenue recognition. A Stipulated Order with the FTC requires compliance actions and prohibits misleading claims. The company is subject to securities class action and derivative lawsuits.
• Debt Covenants: The new credit facility includes covenants for minimum ARR (starting at $106.0 million), minimum liquidity, and future EBITDA requirements (effective June 2027).
• Customer Concentration: One reseller partner accounted for 15.3% of total revenue in 2025.

Investor Verification Checklist

• Internal Control Remediation: Verify the status of remaining material weaknesses in internal controls and the timeline for full remediation.
• Debt Covenant Compliance: Monitor quarterly ARR performance to ensure compliance with the $106.0 million minimum covenant and future EBITDA requirements.
• Legal Resolution: Track the final court approval of the $15.0 million class action settlement and the outcome of the ongoing SEC investigation.
• Revenue Mix: Assess the sustainability of the shift from distributor licensing to direct purchase/subscription models and its impact on gross margins.
• Supply Chain Transition: Evaluate the impact of onboarding Plexus Corp. on manufacturing costs and delivery timelines.